Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 141,999 | 89,792 | 80,151 | 50,132 | 35,407 |
| Depreciation Amortization | 90,117 | 43,930 | 31,121 | 25,727 | 29,845 |
| Income taxes - deferred | -39,230 | 8,018 | 8,890 | -391 | 14,367 |
| Accounts receivable | -14,315 | -8,568 | -13,356 | 11,739 | -28,037 |
| Accounts payable and accrued liabilities | 2,248 | -79 | 4,486 | -3,753 | 312 |
| Other Working Capital | -7,723 | 16,026 | -4,857 | 16,669 | -22,732 |
| Other Operating Activity | 43,688 | 30,960 | 17,331 | 33,536 | 42,136 |
| Operating Cash Flow | $216,784 | $180,079 | $123,766 | $133,659 | $71,298 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -94,388 | -43,308 | -31,832 | -36,387 | -36,406 |
| Net Acquisitions | -3,400 | -571,992 | -10,841 | -42,498 | -55,515 |
| Purchase Of Investment | -15,580 | -16,689 | -21,824 | N/A | N/A |
| Sale Of Investment | 405 | 32,621 | 1,108 | N/A | N/A |
| Investing Cash Flow | $-112,963 | $-599,368 | $-63,389 | $-78,885 | $-91,921 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 133,700 | 594,000 | 6,943 | 188,922 | 41,915 |
| Debt Repayment | -337,305 | -173,862 | -17,026 | -157,541 | -108,085 |
| Common Stock Issued | 27,123 | 26,554 | 3,976 | 2,136 | 118,954 |
| Common Stock Repurchased | -17,997 | N/A | N/A | N/A | N/A |
| Dividend Paid | -1,400 | -2,112 | -1,902 | -1,470 | -729 |
| Other Financing Activity | 639 | -7,449 | -783 | -26,872 | -4,825 |
| Financing Cash Flow | $-195,240 | $437,131 | $-8,792 | $5,175 | $47,230 |
| Exchange Rate Effect | -17,878 | 3,429 | 8,237 | 4,289 | -1,465 |
| Beginning Cash Position | 207,566 | 182,331 | 122,509 | 58,271 | 33,129 |
| End Cash Position | 114,821 | 207,566 | 182,331 | 122,509 | 58,271 |
| Net Cash Flow | $-92,745 | $25,235 | $59,822 | $64,238 | $25,142 |
| Free Cash Flow | |||||
| Operating Cash Flow | 216,784 | 180,079 | 123,766 | 133,659 | 71,298 |
| Capital Expenditure | -94,520 | -44,735 | -32,704 | -37,543 | -36,406 |
| Free Cash Flow | 122,264 | 135,344 | 91,062 | 96,116 | 34,892 |